107 results
Page 4 of 6
DEFA14A
o81ty9eodwbqt1imaoj7
18 Dec 19
Additional proxy soliciting materials
4:31pm
8-K
EX-99.2
oidecsq 1xi8
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.1
ji4fo7 akqlf1c
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
jhlxahms
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.3
t9znr2 x5jht
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.3
eno6brll cd61x
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
EX-99.1
1aix9 wkryf
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
EX-99.2
w498a oqppmug
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
ewv8429
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.1
hln2 896fl
9 May 19
Zafgen Reports First Quarter 2019 Operating and Financial Results
4:26pm
8-K
EX-99.1
vadhcrwgpequ48
11 Mar 19
Results of Operations and Financial Condition
4:12pm
8-K
EX-99.1
84badqi7jkg32pwu
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
8-K
EX-99.1
t1jw wtcp
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am